WallStreetZenWallStreetZen

NASDAQ: HCM
Hutchmed Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Hutchmed earnings were $456.9M for the trailing 12 months ending Dec 31, 2025, with 1,225% growth year over year. The latest HCM earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, HCM reported annual earnings of $456.9M, with 1,111% growth.

HCM past earnings growth

How has HCM's earnings growth performed historically?

Company
1,225%
Industry
53.34%
Market
86.39%
HCM's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HCM's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
HCM's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

HCM earnings history

Current Revenue
$548.5M
Current Earnings
$456.9M
Current Profit Margin
83.3%

HCM Return on Equity

Current Company
45.7%
Current Industry
13.5%
Current Market
28.9%
HCM's Return on Equity (45.7%)... subscribe to Premium to read more.
High Return on Equity Performance

HCM Return on Assets

Current Company
30.2%
Current Industry
5.4%
HCM is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HCM announces earnings.

HCM Return on Capital Employed

Current Company
36.41%
Current Industry
11.6%
HCM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HCM vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HCMN/A$456.91M+110.16%$2.65
PBH$346.27M$186.50M+2.85%$3.81
PAHC$218.76M$92.09M+15.80%$2.27
SUPN$50.51M-$38.55MN/A-$0.68
BHC$3.22B$157.00MN/A$0.42
View Top Pharmaceutical Stocks

Hutchmed Earnings Reports & History FAQ

What were Hutchmed's earnings last quarter?

On HCM's earnings call on Invalid Date, Hutchmed (NASDAQ: HCM) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total HCM earnings for the quarter were N/A. In the same quarter last year, Hutchmed's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Hutchmed stock.

Is Hutchmed profitable or losing money?

As of the last Hutchmed earnings report, Hutchmed is currently profitable. Hutchmed's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $456.91 million, a 1,111.03% increase year over year.

What was HCM's earnings growth in the past year?

As of Hutchmed's earnings date in Invalid Date, Hutchmed's earnings has grown 1,225% year over year. This is 1,171.66 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 53.34%. HCM earnings in the past year totalled $456.91 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.